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activationCyathula prostrata is a medicinal plant that is used in tropical Africa, Asia and Australia to treat many ailments in-
cluding rheumatic fever, dysentery, wounds and eye trouble (Burkill, 1995). Sowemimo et al. (2009) reported
cytotoxicity against a cervical cancer cell line, HeLa, at a concentration of 250 μg/mL. Due to the reported cytotox-
icity, the mode of cell death caused by an ethanolic C. prostrata extract was investigated. Dose–response assays
were carried out using HeLa and U937 cell lines and IC50 values of 100.8 μg/mL and 64.43 μg/mL, respectively,
were achieved. Cisplatin was used as a positive control for all experiments. Cytotoxicity of the plant extract
was not evident when treating normal peripheral blood mononuclear cells. Progression of cells through the
cell cycle, apoptosis and mitochondrial membrane potential was investigated. Arrest of cells in the G0/G1
phase of the cell cycle was evident after 24 h of exposure to the plant extract in both cell lines, but not due to in-
creases in p21 levels. Caspase 8 activationwas evident andnodepolarisation of themitochondrialmembrane and
cytochrome c release was seen in both cell lines. Phosphatidylserine translocation was investigated and con-
ﬁrmed the onset of apoptosis. Thus, it is deduced that exclusive activation of the extrinsic pathway of apoptosis
is caused by the treatment of HeLa and U937 cells with ethanolic C. prostrata.
© 2013 SAAB. Published by Elsevier B.V. All rights reserved.1. Introduction
Normal cells follow an orderly pattern of cell growth, division and
death while cancer cells do not. Cancer is described as a class of disease
inwhich cells display uncontrolled and accelerated proliferation and are
unable to die, leading to their accumulation and expansion (Kasibhatla
and Tseng, 2003). Defective apoptosis has been shown to be amajor fac-
tor in the development and progression of cancer as tumour cells have
the ability to evade apoptosis (Schafer, 1998) and thus represents a po-
tential therapeutic target.
Apoptosis is initiated by extracellular or intracellular signals which
lead to the activation of a cascade of events leading to the degradation
of the cell and is characterised bymorphological changes such asmem-
brane blebbing, cytoplasmic condensation and apoptotic body forma-
tion. Biochemical changes within the cell are also evident including
caspase activation, DNA fragmentation and phosphatidylserine translo-
cation (Elmore, 2007). Twomajor pathways of apoptosis have been de-
scribed. Death-receptormediated apoptosis, also known as the extrinsic
pathway, is mediated by one of several death receptors binding to an
appropriate ligand on the cell surface (Kasibhatla and Tseng, 2003).
This leads to the activation of cysteine-dependent aspartate-directed pro-
teases (caspases) in the cytosol of the cell (Vermeulen et al., 2005).27 41 504 2814.
. Van de Venter).
y Elsevier B.V. All rights reserved.Mitochondria-mediated apoptosis, also referred to as the intrinsic
pathway, is characterised by the release of cytochrome c and other
pro-apoptotic molecules from the mitochondrial intermembrane
space into the cytosol of the cell which, in turn, activates caspases. The
release of cytochrome c and the balance of activity of pro- and anti-
apoptotic members of the bcl-2 superfamily of proteins are associated
with the loss of the outer mitochondrial membrane potential
(Vermeulen et al., 2005) and the state of the mitochondrial membrane
may serve as a marker for the onset of the intrinsic pathway of
apoptosis.
Plants have played an important role in the discovery of anti-cancer
agents. Over 60% of anti-cancer agents have been derived from natural
sources (Cragg and Newman, 2005). Cyathula prostrata (L.) Blume is
an annual, branched herb/shrub reaching a length of approximately
1 m ormore. C. prostrata is widely distributed and can be found in trop-
ical Africa and America and in Asia as well as in Australia. It has many
medicinal uses. The leaves are typically used for treatment against rheu-
matic fever, dysentery, wounds and eye trouble. The sap is traditionally
used as an eardrop to treat otitis and is also applied to skin sores and
burns (Burkill, 1995). It has been reported that an ethanolic extract of
C. prostrata exhibits cytotoxic effects against cervical and breast cancer
cells (Sowemimo et al., 2009).
Although there appears to be no documentation that C. prostrata is
traditionally used as an anti-cancer therapy, the report of cytotoxic ac-
tivity has led to our investigation of themechanism of cell death caused
by the ethanolic extract of C. prostrata.
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2.1. Materials, reagents and chemicals
Cervical (HeLa) cancer and human promonocytic leukaemia U937
cells were purchased from Highveld Biological, South Africa. Cleaved
caspase 8 (Asp391), p21 Waf1/Cip1 (12D1) rabbit and cytochrome-c
(136F3) rabbit antibodies were purchased from Cell Signaling Technol-
ogy, Inc. (Danvers, MA, USA). The Coulter®DNAPrep™ reagent kit, goat
anti-rabbit IgG (H + L chain speciﬁc) and rabbit IgG isotype, both la-
belled with ﬂuorescein (FITC) conjugate, and IsoFlow™ EPICS™ sheath
ﬂuid were purchased from Beckman Coulter (CA, USA). IntraPrep™
permeabilising reagent was purchased from Immunotech (Marseille,
France). Annexin V–FITC/PI kit was purchased from MACS Miltenyi
Biotec (Auburn, USA). CellTiter-Blue® reagent was purchased from
Promega (Madison, WI, USA). RPMI 1640 cell culture medium contain-
ing 25 mM Hepes, 2 mM glutamine and foetal bovine serum was pur-
chased from Thermo Scientiﬁc (Logan, Utah, USA). Digitonin, saponin,
Rhodamine 123 and nonyl-acridine orange were purchased from
Sigma (St. Louis, MO, USA).
2.2. Methods
2.2.1. Cell culture conditions
Cells were cultured in a humidiﬁed atmosphere containing 5% CO2 in
air at 37 °C. The adherent cancer cell line, HeLa, and the suspensionU937
cellswere used for the experimental procedures. The cellswere routinely
maintained in 10-cm culture dishes and 25 cm2 ﬂasks, respectively,
without antibiotics in RPMI 1640 cell culture medium supplemented
with 10% foetal bovine serum. Trypan blue was used to determine cell
viability and cell number.
2.2.2. Plant extraction
C. prostrata (whole plant) was collected from the Olokemeji Forest
Reserve and from the Campus of Obafemi Awolowo University, Ile-Ife
in Nigeria in July 2006. The plant was authenticated by comparison
with corresponding herbarium specimens at the Forestry Research In-
stitute, Ibadan, Nigeria (FRIN) where voucher specimens (FHI 107232)
were also deposited. The plant was air dried for two days followed by
drying in a hot air oven at 40 °C. Thereafter, the dried plant material
was ground to powder and stored in amber coloured bottles. Powdered
plant material (100 g) was macerated with 80% ethanol at room tem-
perature. Extract was ﬁltered and concentrated to dryness in vacuo at
room temperature (Sowemimo et al., 2009). Stocks of the extract
were made fresh on the day of experiment at 100 mg/mL by dissolving
1 mg extract in 10 μL dimethyl sulfoxide (DMSO).
2.2.3. Cytotoxicity
Cytotoxicity assays were performed using CellTiter-Blue. HeLa and
U937 cells were seeded in 200 μL and 100 μL aliquots, respectively, at
3 × 104 cells/mL in 96 well plates and HeLa cells were left overnight
to attach. U937 cell was also incubated overnight at 37 °C before treat-
ment. Themediumwas replacedwith freshmedium containing varying
concentrations (4 to 500 μg/mL) of ethanolic C. prostrata extract for
treatment of HeLa cells. One hundred microlitre aliquots of fresh medi-
um containing double the appropriate extract concentration were
added to the respective wells for treatment of U937 cells. Both cell
lines were incubated at 37 °C in a humidiﬁed 5% CO2 incubator for
48 h. Cisplatin (1.5 μM–100 μM) was used as a positive control and
DMSO (0.05–0.25% v/v) as a vehicle control. Following incubation,
40 μL of CellTiter-Blue reagentwas added to eachwell and cellswere in-
cubated for 2 h at 37 °C, in the dark. Thereafter, 200 μL of supernatant
was transferred from each well to a black 96well microtitre plate. Fluo-
rescencewas read at 544Ex/590Em by using a Fluoroskan Ascent FL Fluo-
rometer (Thermo Labsystems, Finland).Cytotoxicity of an ethanolic extract of C. prostratawas also tested
against peripheral blood mononuclear cells (PBMCs). Blood was col-
lected from a healthy donor and within 30 min after collection,
PBMCs were isolated. Brieﬂy, blood was centrifuged at 1800 ×g for
30 min at 20 °C. The plasma containing PBMCs was transferred to
sterile 15 mL polypropylene centrifugation tubes and centrifuged
at 300 ×g for 15 min. The cell pellet was resuspended gently and
washed with 10 mL growth medium and centrifuged. Washing of
the cell pellet was repeated twice more. The ﬁnal cell pellet was
resuspended in growth medium and cells were seeded in 200 μL ali-
quots at 1 × 106 cells/mL in a 96 well microtitre plate. Cells were
treated with varying concentrations of C. prostrata (16–250 μg/mL),
cisplatin (12.5 and 50 μg/mL) and DMSO (0.05%–0.5% v/v). Treat-
ments were performed in quadruplicate. A viability assay using
CellTiter-Blue was performed after 48 h of treatment as described
above.
2.2.4. Cell cycle analysis
HeLa cells were seeded in 10 cm culture dishes at 1.2 × 106 cells/
10 mL and allowed to attach for 6 h. After attachment, mediumwas as-
pirated and cellswere treatedwith 125 μg/mLof C. prostrata extract and
incubated for 24 and 48 h. U937 cells were seeded at a concentration of
1 × 105 cells/mL and treated and incubated as for HeLa cells. Following
incubation of 24 and 48 h, all cells were harvested and collected in poly-
propylene ﬂow cytometer tubes (Beckman Coulter). Adherent HeLa
cells were trypsinised and re-suspended in 1 mLphosphate buffered sa-
line (PBS). U937 cells did not require trypsinisation. Cells were washed
by centrifugation at 500 ×g for 5 min and resuspended in 1 mL PBS.
This washing step was repeated twice. The DNA Prep kit from Beckman
Coulter was used for DNA cell cycle analysis and the assay was
performed as permanufacturer's recommendationswithmodiﬁcations.
Brieﬂy, 100 μL of lysis buffer was added, tubes very gently vortexed and
incubated for 5 min at room temperature. Thereafter, 500 μL propidium
iodide (50 μg/mL) was added and allowed to incubate for 15 min at
37 °C in the dark. Samples were then analysed immediately on a
Beckman Coulter FC 500 ﬂow cytometer.
2.2.5. Phosphatidylserine translocation
The Annexin V–FITC/PI staining kit (Miltenyi) was used to analyse
phosphatidylserine translocation, a biochemical change evident at a
late stage of apoptosis. Cells were seeded and treated for both 24 and
48 h studies. U937 cells were seeded in 24 well culture plates at a cell
density of 1 × 105 cells/mL. Following incubation with treatments,
cells were transferred to polypropylene tubes and centrifuged at
500 ×g for 5 min. The supernatantwas discarded and the pelletwashed
in 1 mL 1× binding buffer.Washed cells were centrifuged at 300 ×g for
10 min, supernatant discarded and the washing step repeated. Cells
were re-suspended in 100 μL 1× binding buffer, followed by staining.
Annexin V–FITC (1 μL; 25 μg/mL) was added to each tube, vortexed
brieﬂy and incubated in the dark. Cells were then washed as described.
Thereafter, cells were re-suspended in 500 μL (1×) binding buffer
followed by the addition of propidium iodide (5 μL; 250 μg/mL). Sam-
ples were immediately analysed by ﬂow cytometry.
2.2.6. Measurement of intracellular p21 levels
HeLa and U937 cells were seeded at 4 × 104 cells/mL and
1 × 105 cells/mL, respectively. HeLa cells were left to attach for 6 h.
Cells were treated with C. prostrata (125 μg/mL) and cisplatin (50 μM)
separately. Cells were collected and washed using the centrifugation
method as previously described. Cells were ﬁxed and permeabilised
using the IntraPrep permeabilisation kit as per manufacturer's instruc-
tions. p21 Waf1/Cip1 (12D1) rabbit monoclonal antibody was used to
determine p21 levels in the cells. Cells were ﬁrst blocked by using PBS
supplemented with 0.5% BSA and thereafter incubated with p21 anti-
body (1:50). Cells were then stained with goat anti-rabbit IgG
(H + L) mouse/human ads-FITC secondary antibody and incubated
Table 1
Summary of cell cycle analysis results for HeLa and U937 cells after treatment with
125 μg/mL Cyathula prostrata ethanol extract and 50 μM cisplatin.
Cell line Time (h) Treatment % cells in each phase (Ave ± SD; n = 3)
G1/G0 S G2/M
HeLa 24 Vehicle control 45.5 ± 2.0 44.7 ± 0.7 9.8 ± 2.7
Cisplatin 14.8 ± 2.9*** 80.9 ± 1.9*** 4.3 ± 1.3*
C. prostrata 88.3 ± 1.2*** 5.7 ± 1.8*** 6.0 ± 0.7
48 Vehicle control 63.4 ± 4.6 31.8 ± 7.3 4.8 ± 2.7
Cisplatin 3.1 ± 1.8*** 86.6 ± 5.5*** 10.3 ± 6.1
C. prostrata 80.1 ± 6.2* 17.2 ± 4.9* 2.8 ± 1.5
U937 24 Vehicle control 78.2 ± 1.1 15.3 ± 0.4 6.5 ± 0.9
Cisplatin 74.7 ± 0.7** 16.7 ± 1.5 8.6 ± 0.8**
C. prostrata 73.8 ± 0.8* 19.3 ± 1.8* 7.0 ± 1.6
48 Vehicle control 57.9 ± 5.4 31.9 ± 1.8 7.6 ± 1.0
Cisplatin 43.7 ± 0.3* 49.3 ± 1.7** 6.9 ± 1.7
C. prostrata 83.5 ± 1.1** 14.4 ± 1.1*** 2.1 ± 04**
Signiﬁcant differences compared to corresponding vehicle control cell values: *p b 0.05,
**p b 0.01, and ***p b 0.001.
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using ﬂow cytometry. An isotype control of rabbit IgG-FITC was also
prepared and analysed.
2.2.7. Measurement of activated caspase 8
Cells were seeded, treated, ﬁxed and permeabilised as described in
Section 2.2.6. Cleaved caspase 8 (Asp391 18C8) rabbit monoclonal anti-
bodywas used to determine activation of caspase 8. Secondary antibody
staining was performed as described for p21 level analysis.
2.2.8. Mitochondrial membrane potential (Ψm)
To determine a change in the mitochondrial membrane potential
(Ψm), Rhodamine 123 (R123) and nonyl-acridine orange (NAO) were
used. HeLa and U937 cells were seeded and treated as described in
Section 2.2.6 and collected as described in Section 2.2.4. Cell pellets
were resuspended in 0.5 mL R123 or NAO (5 μg/mL) and left to incu-
bate at 37 °C for 10 min. Cells were then centrifuged at 500 ×g for
5 min and the supernatant discarded. Cells were washed twice using
1 mL PBS. The cell pellet was resuspended in 500 μL PBS and analysed
by ﬂow cytometry.
2.2.9. Measurement of cytochrome c release
Cytochrome c release from the mitochondria was measured
according to the method of Waterhouse and Trapani (2003) with modi-
ﬁcations. Brieﬂy, cells were seeded in 24 well culture plates at 1 × 105
and 1 × 106 cells/mL for HeLa and U937, respectively. Cells were treated
with C. prostrata and incubated for 24 and 48 h. Following incubation,
cells were harvested and treated with 100 μL digitonin (50 μg/mL in
Dulbecco's PBS with 100 mM KCl) for 5 min on ice (until N95% of the
cells were permeabilised as assessed by trypan blue exclusion). Cells
were ﬁxed in 4% v/v paraformaldehyde in DPBS for 20 min at room tem-
perature,washed three times in PBS and incubated in blocking buffer (3%
BSA, 0.05% saponin in DPBS) for 1 h. Cells were incubated overnight at
4 °C with 1:100 cytochrome-c (136F3) rabbit mAb in blocking buffer,
washed three times and incubated with 1:200 goat anti-rabbit IgG
(H + L), mouse/human ads-FITC secondary antibody in blocking buffer
for 1 h at room temperature. Cells were then analysed by ﬂow cytome-
try. An isotype control of rabbit IgG-FITC was also used.
2.2.10. Statistical analysis
IC50 values were calculated using GraphPad Prism Version 4.1
(GraphPad software, San Diego, USA). Flow cytometry was performed
using the Beckman Coulter FC500 and a minimum of 10,000 gated
events were recorded for each sample unless stated otherwise. Where
appropriate, data are expressed as mean ± SD in triplicate or quadru-
plicate for each experimental point. The statistical differences between
treated groups and control groups were determined by two tailed
Student's t-test, and the signiﬁcance threshold was set to p b 0.05. His-
tograms obtained from cell cycle analysis were analysed with
MultiCycle software version 4.0 to calculate the percentage cells in
each of the cell cycle phases.
3. Results
3.1. Cytotoxicity
CellTiter-Blue assaywas performed to determine the cytotoxic effect
of an ethanolic extract of C. prostrata on HeLa and U937 cancer cells. The
extract proved to be cytotoxic against both HeLa and U937 cells, yield-
ing IC50 values of 100.8 μg/mL and 64.43 μg/mL respectively. A ﬁxed ex-
tract concentration of 125 μg/mL was used to treat both cell lines for
further experiments. IC50 values of 12.5 and 8 μMwere obtained for cis-
platin on HeLa and U937 cells, respectively. Fifty μM of cisplatin was
used as a positive control for all further experiments.
PBMCs were isolated from blood donated by a healthy individual to
test the cytotoxicity of an ethanolic extract of C. prostrata against normalcells. After a 48 hour exposure of PBMCs to cisplatin, an IC50 of 50 μM
was obtained. The percentage of viable cells after 24 h of exposure to
125 μg/mL extract, a concentration similar to that of the IC50 value
obtained against HeLa cells, was 106.56 ± 4.92%. When PBMCs were
exposed to 500 μg/mL extract for 24 h, a percentage cell viability of
101.57 ± 7.40% was obtained. Only after 48 h of exposure to
500 μg/mL extract was there a decrease of approximately 50% in
the number of viable PBMCs (data not shown).
3.2. Cell cycle analysis
Cell cycle analysis indicates that HeLa cells treatedwith the ethanolic
extract of C. prostrata arrest in the G1/G0 phase of the cell cycle after 24
and 48 h of exposure (Table 1). U937 cells responded more slowly and
the same phase arrest as for HeLa cells was evident after 48 h of expo-
sure. Accumulation of cells in the S phase was evident after treatment
with cisplatin.
3.3. Phosphatidylserine translocation
Dual staining with Annexin V–FITC and PI was used to establish the
integrity of the cell membrane. After 24 h of exposure to C. prostrata, a
signiﬁcant increase in the percentage of apoptotic cells from 4.9% in
the vehicle control to 48.1% was evident. An increase after treatment
with cisplatin was also evident (Fig. 1).
3.4. Measurement of intracellular p21 levels
Levels of the cyclin–CDK inhibitor p21, a gene product of the Cip/Kip
family of genes, are increasedby p53which is triggered byDNAdamage.
p21 halts the cell cycle in the G1 phase by binding to, and inactivating,
cyclin–CDK complexes (Flores-Rozas et al., 1994). Following the obser-
vation of G1/G0 arrest in C. prostrata treated cells, measurements of p21
levels were performed to see whether G1 arrest was due to an increase
in p21 levels. Immune labelling of control and treated cells revealed no
signiﬁcant increase in p21 levels upon C. prostrata treatment for 24 and
48 h (Fig. 2) and thus it is deduced that G1/G0 arrest is not induced by
this pathway.
3.5. Measurement of activated caspase 8
Caspase 8 is an initiator caspase and forms an important part of the
extrinsic pathway of apoptosis. Activated caspase 8 was measured
using immune labelling and ﬂow cytometry. After 24 h of exposure,
no signiﬁcant increase in activated caspase 8 was evident (data not
Fig. 1.Dot plots showingAnnexin V–FITC stainedU937 cells after 24 h (A, B and C) exposure to 0.25%DMSO (A), 50 μMcisplatin (B) and 125 μg/mL C. prostrata (C). Four quadrants represent
unstained/live cells (A3: Annexin V—negative; PI—negative), early apoptotic cells (A4: Annexin V—positive; PI—negative), late apoptotic cells (A2: Annexin V—positive; PI—positive) and ne-
crotic cells (A1: Annexin V—negative; PI—positive). A minimum of 20,000 events were recorded for each sample.
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of exposure to C. prostrata in both HeLa and U937 cells is evident (Fig. 3).3.6. Mitochondrial membrane potential (Ψm)
Mitochondria often play a central role in apoptosis. Measurement of
the mitochondrial membrane potential (ΔΨm), using Rhodamine 123
(R123) was done in conjunction with nonyl-acridine orange (NAO).
NAO results revealed that there was no ﬂuctuation in themitochondrial
mass (results not shown) and therefore differences in R123 staining
could be interpreted as changes in Ψm. Cells treated with C. prostrata
appeared to have no change to the state of the mitochondria in both
cell lines after 24 and 48 h of exposure as indicated in Fig. 4. In contrastFig. 2.Histogram overlays of p21 immunostaining after treatmentwith C. prostrata (…..), cispla
D; U937 (48 h). One representative of 3 individual experiments. A minimum of 10 000 eventscisplatin treatment resulted in a time dependent decrease in the mito-
chondrial membrane potential.3.7. Measurement of cytochrome c release
To conﬁrm the lack of mitochondrial mediated apoptosis a meth-
od developed byWaterhouse and Trapani (2003) that utilises digito-
nin to selectively permeabilise the plasma membrane and keep the
mitochondrial membrane intact was used to investigate cytochrome
c release, the hallmark of the intrinsic apoptosis pathway. Selective
membrane permeabilisation after treatment of the cells allows cyto-
plasmic cytochrome-c to leak out of the cells before ﬁxation. Mitochon-
drial membrane permeabilisation with saponin after ﬁxation providestin (- - -) and vehicle control (____) for A; HeLa (24 h), B; U937 (24 h), C; HeLa (48 h) and
were recorded for each sample.
Fig. 3.Histogram overlays of activated caspase 8 in HeLa (A, C) and U937 (B, D) cells after 24 (A, B) and 48 h (C, D) exposure to C. prostrata (…..), cisplatin (- - -) and vehicle control (____).
One representative of 3 individual experiments. A minimum of 10 000 events were recorded for each sample.
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for immune staining and quantiﬁcation of the amount of cytochrome-c
remaining in themitochondria. The release of cytochrome-cwas not ev-
ident for both HeLa (data not shown) and U937 cells (Fig. 5B and E) after
treatment with C. prostrata for 24 and 48 h, conﬁrming themaintenance
of themitochondrial function. Treatmentwith cisplatin revealed a signif-
icant increase in cytochrome c release which corroborates with the de-
creased mitochondrial membrane potential.
4. Discussion
Plants have been a prime source of highly effective cancer drugs.
Active compounds isolated from plants have led to the development
of anti-cancer drugs (Cragg and Newman, 2005). C. prostrata grows
naturally in Nigeria as well as in other countries such as China
(Zheng and Xing, 2009), Congo (Mbatchi et al., 2006), Ivory Coast
(Kamanzi Atindehou et al., 2004) and Australia (Burkill, 1995). It
has been reported that a methanolic extract of C. prostrata exhibits
anti-inﬂammatory and analgesic activities (Ibrahim et al., 2012)
and antibacterial activity has also been reported (Oladimeji et al.,
2005; Unni et al., 2009). C. ofﬁcinalis is used in China as an herbal
medicine for the treatment of cancer and ﬁve compounds isolated
from this plant have shown to exhibit anti-cancer properties (Rong
et al., 2004). C. prostratawas collected and included in a cytotoxicity
screening experiment of Nigerian plant extracts by Sowemimo et al.
(2009). C. prostrata showed to have cytotoxic effects against HeLa
cells at a concentration of 250 μg/mL. A recent study by Priya et al.
(2013) reported on the anticancer activity of a methanolic extract
of C. prostrata leaves against Daltons ascites in Swiss albino mice. It
was shown that treatment with this extract caused DNA fragmenta-
tion in the cancer cells, which is indicative of apoptosis induction.
Thus the mode of reported cytotoxicity was investigated in the pres-
ent study.Dose–response assays were conducted on both adherent HeLa and
suspension U937 cancer cell lines. Gertsch (2009) questioned the value
of extracts being used at high concentrations of N200 μg/mL as such con-
centrations will likely display artiﬁcial results in in vitro assays. Previous
studies have indicated that C. prostratamay possess potential anti-cancer
properties, however the cytotoxic effect was only determined a single
concentration of 250 μg/mL (Sowemimo et al., 2009). A more compre-
hensive characterisation of the cytotoxicity yielded IC50 values of
100.8 μg/mL and 64.4 μg/mL against HeLa and U937 cells, respectively,
and thus may be considered to be biologically relevant. Furthermore,
using peripheral blood mononuclear cells (PBMCs) as a model for cells
that do not divide frequently in culture, the speciﬁcity of C. prostrata as
an anti-proliferatory/cytotoxic agent could be established. PBMCs were
relatively insensitive to the toxic effects of C. prostrata as judged from
the IC50 value of N500 μg/mL after 48 h of exposure.
DNA cell cycle analysis was performed to determine which phase
of the cell cycle arrests in, if at all (Table 1). After 24 h of exposure to
C. prostrata, an arrest in the G0/G1 phase of the cell cycle was evident
for HeLa cells relative to the vehicle control. The same was evident
after 48 h of exposure for U937 cells. Upon treatment of cells with
cisplatin, cells arrest in the S phase of the cell cycle as would be
expected from the known mechanism of DNA damage. The mecha-
nism of G0/G1 arrest cannot be deduced by PI staining of DNA. In
the G1 phase, DNA damage activates p53, which in turn, activates
the expression of p21, a cyclin dependent kinase (Cdk) inhibitor. In
the presence of p21, cyclin D is destabilised and this leads to redistribu-
tion of p21 from Cdk4 to Cdk2 and this also contributes to an arrest in
G1 (Cheng et al., 1999; Huang et al., 2005). Due to the evident arrest
of cells in G0/G1, p21 levels were investigated using ﬂow cytometry.
Histogram overlays in Fig. 2 show that no increase in p21 levels was ev-
ident after 24 and 48 h of exposure to C. prostratawhen comparing the
result to the vehicle control cells. Thus, it is deduced that G0/G1 arrest is
not caused by an increase in p21 levels and it can therefore be assumed
Fig. 4.Measurement of changes in themitochondrial membrane potential of HeLa (A–F) and U937 (G–L) cells after 24 and 48 h using R123 ﬂuorescent dye. Region “C” indicates percent-
age of cells with depolarisation of the mitochondrial membrane. One representative of 3 individual experiments. A minimum of 10,000 events were recorded for each sample.
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C. prostrata, cisplatin treatment, which is known to induce DNA dam-
age, increased the levels of p21, however the effect was more pro-
nounced in HeLa cells than in U937 cells.
During apoptosis phosphatidylserine is translocated from the inner
surface of the plasma membrane to the outer surface. Annexin-V has a
high afﬁnity for the negatively charged PS and thus it is used to deter-
mine the presence of PS on the outer surface of the cell (Van Engeland
et al., 1998). U937 cells were treated with C. prostrata and cisplatin sep-
arately and analysed after 24 h of exposure. Fig. 1 shows the result of this
assay. After 24 h of treatment, an increase in the percentage of apoptotic
cells was evident through increased Annexin-V staining. No increase in
PI positive cells was observed in this study, thus indicating that necrotic
cell death is unlikely and cell death is caused by the onset of apoptosis as
a result of exposure to C. prostrata. PS translocation analysis was not
conducted on HeLa cells as trypsin damages the cell membrane, which
is used to detach the cells from the culture plates. This damage leads toPS translocation and will therefore result in false positive data (Van
Engeland et al., 1996).
Cellular changes during apoptosis occur after a cascade of cell sig-
nalling and caspase-mediated events triggered by one of or both ap-
optotic pathways, namely the death-receptor induced extrinsic
pathway or the mitochondria–apoptosome intrinsic pathway. Both
pathways lead to caspase activation (Hu and Kavanagh, 2003).
Caspases are divided into 2 groups, the initiator and the executioner
caspases. Caspase 8 is an initiator caspase that, once cleaved and activat-
ed, initiates apoptosis via a mitochondria-dependent or -independent
pathway. In themitochondria-independent pathway, caspase 8 will ac-
tivate the executioner caspase, i.e. caspase 3, without exerting an effect
in the mitochondria. The mitochondria-dependent pathway induces
apoptosis by depolarisation of themitochondrialmembrane and the re-
lease of pro-apoptotic proteins and cytochrome-c into the cytosol of the
cells (Fulda and Debatin, 2006). The activation of caspase 8 after expo-
sure to C. prostrata was investigated using immunochemistry and ﬂow
Fig. 5.Measurement of cytochrome c in themitochondrialmembranes of U937 cells after 24 and 48 h of treatment. A, D; vehicle control, B, E; C. prostrata, C, F; cisplatin. One representative
of 3 individual experiments. A minimum of 10,000 events were recorded for each sample.
386 G.E. Schnablegger et al. / South African Journal of Botany 88 (2013) 380–387cytometry. After 48 h of treatmentwith the plant extract, an increase in
activated caspase 8was evident in both cell lines (Fig. 3). This suggested
that the cells respond to the plant treatment via the death-receptor ex-
trinsic apoptotic pathway.
Although activation of caspase 8 is evident in both cell lines upon
treatment with C. prostrata which suggests the onset of a death-
receptor mediated mechanism, mitochondrial depolarisation and
cytochrome c release were investigated to conﬁrm the absence of
an intrinsic apoptosis pathway which is dependent in the mitochon-
drial involvement. Figs. 4 and 5 show the results of this investigation.
R123 and NAO staining were performed to determine the state of the
mitochondrial membrane potential after exposure to the plant ex-
tract. R123 is a ﬂuorescent dye that binds speciﬁcally to, and accu-
mulates in the mitochondrial membrane in accordance to the
transmembrane potential. The accumulation of R123 and thus ﬂuo-
rescence intensity is directly proportional to changes in the mito-
chondrial membrane potential. NAO was used to conﬁrm that these
differences were not due to alteration in the mitochondrial mass
(Petit et al., 1990; Ratinaud et al., 1988). No increase or decrease in
the mitochondrial mass was detected (data not shown). In Fig. 4A,
D, G and J, R123 accumulated in the control cells of themitochondria,
yielding high ﬂuorescence intensities as is evident from the peak.
Cells with lower membrane potential were detected in the region
marked “C” of each histogram. A decrease in Ψm will therefore be
noted by any increase in the percentage cells in region “C” and com-
pared to the vehicle control of DMSO. Cells treated with C. prostrata
showed to have no signiﬁcant increase in percentage cells in region
“C”, i.e. depolarisation of the membrane is not evident after 24 and
48 h of treatment in both cell lines (Fig. 4C, F, I and L). The positive
control, cisplatin, showed to have a signiﬁcant effect in the mito-
chondrial membrane in accordance to the involvement of the intrin-
sic apoptotic pathway. Depolarisation of the membrane is clearly
evident by the increase in the percentage of cells in region “C” ofthe histograms (Fig. 4B, E, H and K). Pro-apoptotic proteins are normally
released from the mitochondria if depolarisation of the membrane oc-
curs. One such protein is cytochrome c. Because depolarisation was
not evident after treatment with C. prostrata, no change in cytochrome
c levels was expected (Fig. 5B and E). Cisplatin showed to have a de-
crease in cytochrome c associated with the mitochondrial membrane
(Fig. 5C and F), as expected due to depolarisation of the mitochondrial
membrane after treatment.
Taken together our results, for the ﬁrst time, argue in favour of a
cytotoxic mechanism involving the activation of the extrinsic path-
way of apoptosis in HeLa and U937 cells treated with an ethanol ex-
tract of C. prostrata. The activation of caspase 8 and an increased
translocation of PS to the cell surface without any signiﬁcant PI stain-
ing indicate that the cytotoxicity involves apoptosis. Furthermore,
the absence of themitochondrial involvement in the cytotoxic mech-
anism suggests that C. prostrata causes apoptosis by activating the
death-receptor extrinsic pathway only. Generally, plant extracts
that induce apoptosis do so with involvement of both extrinsic and
intrinsic pathways, making this a novel ﬁnding that requires further
investigation.
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